An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Cell2021Vol. 184(13), pp. 3452–3466.e18
Citations Over TimeTop 1% of 2021 papers
Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa, Mika Hirose, Emi E. Nakayama, Songling Li, Miwa Sasai, Tatsuya Suzuki, Asa Tada, Akemi Arakawa, Sumiko Matsuoka, Kanako Akamatsu, M. Matsuda, Chikako Ono, Shiho Torii, Kazuki Kishida, Hui Jin, Wataru Nakai, Noriko Arase, Atsushi Nakagawa, Maki Matsumoto, Yukoh Nakazaki, Yasuhiro Shindo, Masako Kohyama, Keisuke Tomii, Koichiro Ohmura, Shiro Ohshima, Toru Okamoto, Masahiro Yamamoto, Hironori Nakagami, Yoshiharu Matsuura, Atsushi Nakagawa, Takayuki Kato, Masato Okada, Daron M. Standley, Tatsuo Shioda, Hisashi Arase
Related Papers
- → Structural Analysis of Spike Protein Mutations in the SARS-CoV-2 P.3 Variant(2021)11 cited
- → Author response for "Conformational variability of loops in the SARS‐CoV ‐2 spike protein"(2021)
- → Review for "Conformational variability of loops in the SARS‐CoV ‐2 spike protein"(2021)
- → Faculty Opinions recommendation of Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses.(2023)
- → Retraction Note: Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome.(2024)